The antigenic relationships between seven members of the tick-borne encephalitis complex of flaviviruses (group B arboviruses) were examined by raising a library of 16 monoclonal antibodies against one of them and examining their biological and antigenic properties. These clones reacted with only one of two intracellular, virusspecific polypeptides. One polypeptide [mol. wt. 58 × 103 (58K)] is related to the major envelope protein E, but the identity of the other is at present unknown, even though it is a major immunogen in experimental infections and vaccinations. Only those clones specific for the 58K polypeptide contain either neutralizing or haemagglutinininhibiting activity, but these epitopes are not identical. In general, epitopes on the 51K polypeptide were more heavily conserved than those on the 58K polypeptide, although both conserved and variant epitopes were found on both polypeptides. One epitope was present on the 51K polypeptide which was conserved on all seven isolates studied and another epitope on the same polypeptide was specific for all the western isolates including one isolate of louping-ill virus. Using the monoclonal antibodies raised in the study, it was shown that louping-ill virus was closely related antigenically to isolates of the Western subtype of tick-borne encephalitis virus.
INTRODUCTION
Tick-borne encephalitis (TBE) is the most important arthropod-transmitted disease in Europe and for several years has raised a significant health problem in several countries, especially Austria, Czechoslovakia and Russia. In addition, the disease is now established in southern areas of Germany and has been reported in virtually every European country. Although no cases of TBE have been reported in the U.K., a similar animal disease has been prevalent there for several years and isolates have been obtained from several wild and domestic animals and birds (Reid et al., 1978; Bannatyne et al., 1980) . The TBE group of viruses, in common with other flaviviruses, appears to contain a major envelope glycoprotein (E) on which reside the biological properties associated with the virion particle (Heinz et al., 1981) . Moreover, antibodies against an infected cell-specific polypeptide related to this protein have been shown to be responsible for eliciting neutralizing antibodies and a protective immune response in experimental animals (Hambleton et al., 1983) . By using a library of monoclonal antibodies, we have attempted to determine whether these biological activities are the property of a single group of determinants or if each biological activity is the function of a separate group of determinants on the E protein. In addition, these monoclonal antibodies have been used to determine antigenic variation among virus isolates from a wide geographical origin as well as between isolates from diseases of animal origin. Thus, distinctions can be made between isolates that, by conventional serology, appear to be identical, even though some of their other properties, such as the size of their envelope polypeptides and their host specificity are different.
0022-1317/84/0000-5842 $02.00©1984 SGM Preparation and purification of antigens. All viruses were grown by intracerebral inoculation into suckling "Porton' mice. After 4 to 5 days, brains were harvested, homogenized in borate buffer (0-12 M-NaCI, 0-05 M-boric acid, pH 9.0), clarified by centrifugation at 2000 g and 4 °C for 20 rain and stored at -70 °C. Immediately before use, infected homogenates were thawed, resuspended in a sonicating water-bath and centrifuged at 85 000 g at 4 °C for 20 h on a discontinuous density gradient consisting of 5 m150% (w/w) sucrose in gradient buffer (0.185 M-Naz-HPO4, 0.114 M-KH2PO4, 0.13 M-NaC1, pH 8.0), 10 ml 30% (w/w) sucrose and 20 ml of homogenate. The virus material accumulating at the interface between the 50% and 30% sucrose layers was harvested, diluted 3 or 4 times in gradient buffer and submitted to a further round of centrifugation. The final preparation of purified virus was harvested, assayed for protein by the Bio-Rad protein assay and its protein content adjusted to 50 ~tg/ml in bicarbonate buffer (50 mM, pH 9.5). All antigens were stored at 4 °C in the presence of sodium azide (0.001%). Each batch of antigens was analysed for purity by SDS-polyacrylamide gel electrophoresis (SDS PAGE) and contained less than 5 % of non-viral-specific protein. Apart from the Sophin isolate whose early passage history is not known, all experiments reported here were performed on virus preparations within 3 to 6 mouse brain passages from the original isolate.
Preparation ofmonoclonal antibodies. The procedure used to produce antibody-secreting hybridomas was based on that described by Fazekas de St. Groth (1980) . Spleens from immunized BALB/c mice were removed on the third day after the final boost and a cell suspension obtained by forcing the tissue through a fine mesh. Red cells were removed by incubating the suspension in 0.17 M-NH4C1 for 10 min at 4 °C and the remaining spleen cells were washed three times in serum-free RPMI 1640 growth medium.
The myeloma cell line NSI/1-Ag4-1 (K6hler et al., 1976) was harvested in exponential phase and the cells also washed three times in serum-free RPMI 1640. Spleen cells (2 × l07) were then fused with 5 × 107 myeloma cells using 43% polyethylene glycol 4000 with 5% dimethyl sulphoxide and the resulting fusion mixture plated on 9 × 24 well plates containing peritoneal exudate feeder cells in RPMI 1640 with 10% foetal bovine serum and hypoxanthine aminopterin + thymidine (Littlefield, 1964) . After 7 days, the plates were fed with 1 ml of fresh medium, and the supernatants were tested for antibody after 12 to 17 days by enzyme-linked immunosorbent assay (ELISA). Hybridomas secreting specific antibody were subcultured into 25 cm 2 flasks prior to freezing down in liquid nitrogen and cloning. Cloning was carried out by limiting dilution in 96-well plates using growth medium without aminopterin and peritoneal exudate feeder cells. Plates were fed after 7 days and 6 to 10 monoclonal wells tested for antibody on the 10th day. Three positive clones were retained, two frozen down and the third recloned immediately in the same way.
Purification ofmonoclonal antibodies. Tissue culture supernatants were clarified by centrifugation at 2000 g and 4 °C for 5 min, mixed with 0.5 vol. of phosphate buffer (0.1 M, pH 8.0) and adjusted to pH 8-0 with Tris base. The solution was then, at 4°C, passed slowly over a 1.5 ml column (total binding capacity 40 mg IgG) of Protein A, covalently linked to Sepharose-4B. The column was washed with phosphate buffer until no more u.v.-absorbing material was eluted. Bound antibody was eluted by washing the column with citrate buffer (0.1 M, pH 3.5) and immediately the pH of the eluate was adjusted to 8-0 by the addition of Tris base. The protein concentration of the monoclonal solution was estimated by the Bio-Rad assay and adjusted to 1 mg/ml. The purity of these solutions was checked by SDS-PAGE and never revealed any proteins other than immunoglobulin after staining with BioRad silver stain. Monoclonal solutions were stored at 4 °C in the presence of sodium azide and aprotinin.
Radioirnmunopreeipitation (RIP).
Infected cell lysates were labelled with [35S]methionine, as described by Hambleton et al. (1983) . RIP assays were performed as described by Stephenson et al. (1980) using 200 ~tl of clarified lysate and either 2 btl of animal serum or 20 ixl of purified monoclonal solution, except that the mixtures of antibody and antigen were made 0-01 ~ with respect to SDS immediately before the addition of Protein A.
Polyaerylamide gel electrophoresis (PAGE).
Samples were run for 2 h at 250 V on 15~o discontinuous SDS gels under denaturing conditions as described by Stephenson et al. (1977) .
Isotypic analysis. The class, subclass and type of each monoclonal antibody preparation were determined by a micro-double-diffusion assay in agar. Solutions of monoclonal antibody (10 ~tl at 1 mg/ml) were allowed to react with 10 ~tl of undiluted reconstituted rabbit sera raised against the relevant mouse immunoglobulin. After 48 h at 4 °C, the agar gels were dried, washed thoroughly in phosphate-buffered saline (PBS) and stained with PAGE blue
(BDH).
Assay for virus neutralization. The PS line of porcine kidney cells was obtained from J. S. Porterfield, and handled under conditions stipulated by the U.K. Ministry of Agriculture, Fisheries and Food. Virus was grown in suckling mouse brain as described above and diluted to about 100 to 200 p.f.u./ml in L15 medium. Monoclonal antibody solutions were also diluted in LI 5 medium and 0-5 ml mixed with l0 I1l rabbit serum raised against mouse immunoglobulins, left at room temperature for 30 min and then mixed with 0.5 ml of diluted virus. After incubation at 37 °C for 2 h, 0.2 ml of antibody-virus mix was added to 0.5 ml of PS cell suspension (prepared as described by de Madrid & Porterfield, 1974) 
Haemagglutination-inhibition (HAl) assays. Monoclonal antibody solutions were titrated by doubling dilutions in
Sorensen's citrate buffer (0.15 M-NaC1, 0" 1 M-sodium citrate, pH 6.2) in microtitre plates. Antigen was purified from infected mouse brain material as described above and each dilution of serum was incubated overnight at 4 °C with 4 haemagglutination units. A suspension of goose red blood cells (0.2~o) was added to each antibody dilution and the titres read after 30 rain. The HAI titre of a serum was taken as the midpoint between that dilution of a 1 mg/ml solution which caused total agglutination and that which caused none.
ELISA assays. TBEV antigen was grown in mouse brain and purified as described above. Aliquots (100 ~tl) were added to each well of Linbro E.I.A. microtitration plates and left overnight at room temperature. The plates were then drained and washed four times with 100 txl aliquots of PBS plus 0.1 ~ (v/v) Tween 20 (PBST). Solutions of monoclonal antibodies were diluted in PBST, 100 txl aliquots added to each well of the titration plate and incubated at room temperature for 2 h with rocking. The plates were drained, washed as before and 100 ~tl aliquots of peroxidase-conjugated rabbit IgG raised against total mouse immunoglobulins (4 to 10 ~g/ml in PBST) were added. After a further 2 h incubation at room temperature, the plates were drained and washed as before. A fresh solution of 5-amino salicylic acid (1 mg/ml in water) was prepared and adjusted to pH 6-0 with NaOH. A fresh 0.2 vol. of H202 was prepared and mixed with 9 times its volume of 5-amino salicylate solution. Aliquots of this final mixture (100 Ixl) were then added quickly to each well and incubated at room temperature for 30 rain. The A4so of each well was read on a Titretek Multiskan Spectrophotometer. The ELISA titre was calculated as follows. The A450 readings were fed into a standard linear-regression programme, devised for a Sinclair ZX Spectrum Microcomputer by A. C. Walkland of this laboratory. The linear portion of the titration curve thus generated was selected and a regression line generated. The point at which this regression line crossed a similar line generated by dilutions of a negative serum was determined as being the 'ELISA titre'. Thus, all ELISA titres refer to that titre generated by serial dilutions of 100 Ixl aliquots of a I mg/ml solution of purified antibody against 100 ~tl aliquots of a 50 ~tg/ml solution of purified antigen.
Reagents. Aprotinin was obtained from Sigma, Protein A-Sepharose-4B from Pharmacia and L-
[35S]methionine and 14C-methylated protein molecular weight markers from Amersham International. Rabbit sera raised against mouse immunoglobulins and mouse immunoglobulin isotypes were purchased from Dako.
RESULTS

Production, screening and characterization of TBEV-specific monoclonal antibodies
Four groups of mice were primed and boosted with formalized CTEN as described in Methods and designated as in Table 2 . Hybridomas from each fusion were screened by ELISA assays against formalized CTEN, cloned twice and purified on Protein A-Sepharose-4B, as described in Methods. Only the IgG class of antibody was produced regardless of the immunization schedule, although all four subclasses of IgG, 1, 2A, 2I~ and 3, were represented by at least one antibody clone. All hybridomas, regardless of immunization schedule, produced antibodies of the Kappa type only. Clone T16 reacted well with commercial rabbit sera raised against total mouse IgG, but did not react with any of the subclass-specific sera; similarly, its * The immunization schedules for the fusions were as follows: groups A and C, one intravenous (i.v.) dose, followed by one i.v. boost 8 days later; group B, one intraperitoneal (i.p.) dose, followed by an i.p. boost 7 months later and a final i.v. boost 7 days after that; group D, one i.v. dose, followed by i.v. boosts after 6 days, 10 days and 13 days.
IP: 54.70.40.11 Neutralization neutralization  titre  T4  < I0  < i0  < 2  T6  < 10  < 10  64  T7  < 10  < 10  2  T9  < 10  < 10  1024  T11  < 10  20000  < 2  T12  <10  <10  <2  T13  < 10  16000  <2  T15  <10  <10  <2  T16  <10  <20  <2  T17  <10  <10  <2  T18 < 10 40000 128 T33/1 < 10 < 10 <2 T33/2 < 10 15000 1024 T33/3 < 10 < 10 <2 T35/1 < 10 < 10 256 T35/3 < 10 < 10 <2 85 light chain type could not be detected by the methods employed in this study. The polypeptide specificity of each clone was determined by RIP and a typical result shown in Fig. 1 . Both the 58K and 51K polypeptides are the major immunogens during natural infections or when formalized virus, or commercial vaccines are used to raise animal sera (Fig. 1 , lane 5 and Hambleton et al., 1983) . Recent results in our laboratory (J. R. Stephenson & A. J. Crookes, unpublished data) have indicated that the 58K intracellular polypeptide is closely related to the major envelope glycoprotein (E), but the nature of the 51K intracellular polypeptide is not known. The production of monoclonal antibodies against either polypeptide did not seem to be influenced by the design of the immunization schedule, nor were they restricted to any immunoglobulin subclass.
TBEV antigenic variation
Biological activities of CTEN-specific monoclonal antibodies
The library of antibody clones was assayed for their activities against two biological activities associated with the virus particles, namely infectivity and haemagglutination (Table 3) . HAI activity was only demonstrated in clones directed against the 58K polypeptide.
An unusual feature of these antibody clones was their complete inability to neutralize the parent virus, regardless of their polypeptide specificity. However, if the neutralization assays were performed in the presence of rabbit antibody raised against total mouse immunoglobulins ('assisted neutralization'), several neutralized the virus to high titres (Table 3) . Again, only antibodies specific for the 58K polypeptide were capable of'assisted neutralization'. Moreover, there was no direct correlation between HAI and 'assisted neutralization', suggesting that these two activities reside on different parts of the molecule.
Antigenic comparison of three Austrian TBEV isolates
When this collection of TBEV-specific antibody clones were reacted in an ELISA assay against the homologous antigen, variations in titre up to three orders of magnitude were observed (Table 4 ). Group I represents epitopes which are conserved in all three isolates; group II represents epitopes which are conserved in CTEN and CTES, but have undergone a change in CTEH; group III represents epitopes which are conserved in CTEN and CTEH, but have been altered in CTES. The epitopes represented by the antibodies in group IV appear to have undergone the most antigenic change as they have varied ELISA titres in all three isolates. It is of interest to note that all the most heavily conserved epitopes (group I) reside in the 51K polypeptide and four of the five most variant epitopes reside on the 58K polypeptide. No clear correlation between the polypeptide specificity of the other antibody clones and extent of mutation of the epitope they represent was observed. In addition, there was no evidence to suggest that the epitopes representing the HA and antibody neutralization sites were either conserved or unstable. 
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Comparison of the antigenic structure of three Austrian isolates of TBEV
Clone CTEN* CTES* CTEH* Group I  T12  11300  9450  9000  T16  659  636  570  T 17  267 000  256 000  646 000  Group II  T18  7500  4500  117  T33/2  3280  2110  748  T33/3  22500  18 400  3950  Group III  T6  5500  266  2800  T7  7870  610  7500  T15  2930  360000  2860  T33/1  17700  113000  11200  T35/1  925  81  1100  Group IV  T4  18600  440000  310  T9 245 000 6200 20 000 T11 62500 3800 710 T 13 13 200 2600 1100 T35/3 819 < 20 < 20 * Reciprocal ELISA titres obtained as described in Methods. T4  18 600  298  72  890  T6  5500  1340  1170  620  T7  7870  164  10 900  250  T9  245 000  19300  14 300  9500  T11  62500  22  28  180  T12  11 300  18000  181  5  T 13  13 200  2230  116  8400  T 15  2930  1300  740  4830  TI6  659  2690  1810  688  T 17  267 000  437 000  239 000  94800  T18  7500  665  2150  301  T33/1  17 700  21000  6600  7900  T33/2  3250  526  740  12100  T33/3  22500  550  730  840  T35/1  925  < 20  < 20  790  T35/3  819  558  <20  59 * Reciprocal ELISA titres obtained as described in Methods.
Antigenic comparison of an Austrian isolate of TBEV with isolates of wider geographical origin
When TBEV isolates from Czechoslovakia, Russia (Far-Eastern strain) and Turkey are compared with the standard Central European isolates of TBEV (CTEN) (Table 5), the widely varying ELISA titres demonstrate a considerable amount of antigenic variation between these isolates, much greater than that found between the Austrian isolates. However, the epitopes represented by clones T16, T 17 and possibly T33/1 continue to show a relatively stable antigenic structure. Conversely, the epitope represented by clone T12, while maintaining a constant antigenic structure in all the Austrian isolates, appears to vary considerably in this second group of viruses with the notable exception of HYPR.
Antigenic comparison of an Austrian TBEV isolate with a Scottish isolate of louping-ill virus
In order to examine the antigenic relationships between TBEV and touping-ill virus, the reactions between one isolate of each and the library of monoclonal antibodies were compared (Table 6 ). Of the three epitopes which remain constant in the three Austrian isolates (Table 4, Table 6 .
TBEV antigenic variation Comparison of the antigenic structure of TBEV and louping-il! virus
Clone CTEH* LI3* Group I  T12  I 1300  7990  T 15  2930  2640  TI7  267000  716000  T33/1  17700  24 700  T35/1  925  2140  Group II  T7  7870  1311  T9  245 000  57 600  T13  13200  3770  T33/2  3280  567  T33/3  22500  6650  T35/3  819  117  Group III  T4  18 600  57  T6  5500  91  T11  62500  114  T16  659  6990  TI8 7500 398
* Reciprocal ELISA titres obtained as described in Methods.
87 group I), two (represented by T12 and T17) are found in group I in Table 6 , indicating the similarity of this isolate and louping-ill virus. Moreover, the other epitopes in group I of Table 6 (represented by T15 and T33/1), which have a similar antigenic structure in both the CTEN and louping-ill viruses, demonstrate similar ELISA titres in two of the three Austrian isolates. However, the epitope represented by T16 appears to differ significantly in this isolate of louping-ill virus. The second group of clones in Table 6 represent epitopes with slight changes in antigenicity between CTEN and LI3 ; the third group represents the most variable epitopes. Of the five dissimilar epitopes in the three Austrian isolates, two (represented by T4 and T 11) show a similar disparity between CTEN and louping-ill virus, while the other three (represented by T9, T13 and T35/3) appear in group II. Therefore, this isolate of louping-ill virus shows a close antigenic relationship to the Western subtype of TBEV. In several instances above, higher ELISA titres are recorded for some clones with a heterologous isolate than are recorded for the homologous virus. This feature is frequently observed with several viruses from the TBE complex when using neutralization and ELISA assays to titre conventional polyclonal sera (Hambleton et al., 1983) .
DISCUSSION
Antigenic variation among seven members of the TBE complex of flaviviruses has been studied by preparing monoclonal antibodies against a formalized preparation of a Central European isolate currently used to prepare a commercial vaccine. The inactivation step is essential as these viruses are highly pathogenic for the strains of mice used in this study. These monoclonal antibodies were all of the IgG class and all four subclasses were represented by at least one clone, but this was not apparently dependent on the immunization schedule employed. In addition, all clones contained light chains of the Kappa type. All antibody clones employed in this study reacted with only one of two infected-cell-specific polypeptides ( Table 2) . One of the intraceUular polypeptides (58K) is closely related to the major envelope protein (E) which has been shown to contain the major biological properties of this virus (Heinz et al., 1981) .
Similar results have been recently reported for yellow fever virus by Schlesinger et al. (1983) . Their study also demonstrated that monoclonal antibodies raised against virus react with only one of two infected-cell-specific polypeptides, only one of which is directly related to the major virion envelope glycoprotein. Moreover, these authors also found that the HAI and neutralization functions are only demonstrated by clones directed against the intracellular polypeptide related to E. They also suggest that as the only biological activity demonstrated by clones specific for the smaller (48K) polypeptide is complement fixation (CF), this 48K polypeptide could represent the soluble CF antigen reported for this virus. It is possible, therefore, that the 51K polypeptide reported here for TBEV has a similar function, but unfortunately, as no reliable CF test can be demonstrated for this isolate of TBEV, the hypothesis cannot be tested directly. Although neutralization was demonstrated against the 58K polypeptide, it was only in the presence of a second antibody directed against mouse immunoglobulins. The mechanism whereby this phenomenon operates is obscure, but a similar finding has been reported for monoclonal antibodies directed against an envelope glycoprotein of another togavirus, Sindbis virus (Chanas et al., 1982) . It is possible that the second antibody is necessary to concentrate sufficient neutralizing antibodies in one area to induce any possible conformational changes necessary to convert the virus particle to the neutralized state. Also of interest is the observation (Table 3 ) that the neutralization and HA epitopes are not identical. Studies with other flaviviruses such as West Nile (Peiris et al., 1982) and yellow fever (Schlesinger et al., 1983 ) also demonstrate a similar division between HAI activity and neutralization. These findings would support the hypothesis that neutralization is not just a matter of blocking the sites of virus attachment (Possee & Dimmock, 1981 ; Possee et al., 1982) .
When the antigenic relationship between the Austrian isolates was examined by reacting the library of monoclonal antibodies against purified formalized virus in an ELISA assay, a wide range of titres were observed and four broad groups of epitopes could be distinguished. Group I (Table 4 ) demonstrated the greatest degree of conservation and all were present on the 51K polypeptide. The epitope represented by T12 was also conserved when both the HYPR isolate and the louping-ill virus isolate were analysed and could thus distinguish all Western subtype isolates. Not only could the louping-ill virus isolate be grouped along with the other western isolates by this clone, but the general overall reactivity in the ELISA test between all clones and this isolate (Table 6 ) would indicate a much closer relationship between louping-il! virus and Western subtype TBEV than has been previously assumed. Clone T17, on the other hand, represented an epitope which was heavily conserved in all isolates. The epitopes in groups II and III, which were moderately conserved in the Austrian isolates, were present on either the 58K or 51K polypeptide. Similar conserved epitopes have been reported by Heinz et al. (1982) , but we have been able to report here that other unstable epitopes (T9, T11, T13 and T35/3) are present in the 58K polypeptide (Table 2 and Table 4 , group IV). In the epitopes studied above, there appears to be no correlation between antigenic stability and HA or neutralization activity. In the experiments reported here, it is noticeable on several occasions that the ELISA titre obtained with a heterologous isolate is frequently higher than that obtained with the homologous virus. Similar results have been reported with polyclonal sera directed against these viruses (Hambleton et al., 1983) and with monoclonal antibodies directed against yellow fever virus (Schlesinger et al., 1983) . Presumably, this results from a tighter fit being obtained between a particular epitope from the heterologous virus than that obtained between a particular antibody molecule and the epitope on the virus against which it was raised.
Thus, while it has been shown that there are conserved epitopes on TBEV-specific proteins, the highest level of conservation is found on the 51K polypeptide. The 58K polypeptide (i.e. related to E) also contains some conserved epitopes, but in addition contains several highly variant epitopes.
